SCHEMBL1375442

SCHEMBL1375442

CCOC(=O)c1cc2cccnc2n(-c2ccc3c(c2)OCCO3)c1=O

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.48
RAB9A P51151 5/20 0.48
SMN1; SMN2 Q16637 4/20 0.48
KDM4E B2RXH2 4/20 0.48
NPC1 O15118 4/20 0.48
HSD17B10 Q99714 5/20 0.44
MEN1 O00255 4/20 0.44
KMT2A Q03164 4/20 0.44
HPGD P15428 4/20 0.44
MAPK1 P28482 3/20 0.44
ALOX15 P16050 3/20 0.44
MAPT P10636 6/20 0.44
LMNA P02545 3/20 0.44
GAA P10253 1/20 0.43
TSHR P16473 4/20 0.42
PKM P14618 1/20 0.42
ELANE P08246 1/20 0.42
USP2 O75604 1/20 0.42
TP53 P04637 1/20 0.42
TGFBR1 P36897 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1373736 0.84 RAB9A (0.43) ALDH1A1RAB9AKDM4ENPC1MEN1
SCHEMBL1375494 0.82 MET (0.52) ALDH1A1KDM4EHSD17B10HPGDALOX15
SCHEMBL1375781 0.81 ALDH1A1 (0.40) ALDH1A1RAB9AKDM4ENPC1HSD17B10
SCHEMBL1376319 0.78 ELANE (0.44) ALDH1A1KDM4EHSD17B10HPGDMAPT
SCHEMBL3517555 0.76 ELANE (0.49) ALDH1A1KDM4EHPGDGAATSHR
SCHEMBL1372818 0.76 AHR (0.55) ALDH1A1KDM4EHSD17B10KMT2AHPGD
SCHEMBL1373580 0.76 RAB9A (0.41) ALDH1A1RAB9AKDM4ENPC1MEN1
SCHEMBL1376548 0.76 ELANE (0.43) ALDH1A1SMN1; SMN2KDM4EHSD17B10HPGD
SCHEMBL2782842 0.73 ALDH1A1 (0.54) ALDH1A1RAB9ASMN1; SMN2KDM4ENPC1
SCHEMBL16410105 0.73 ALDH1A1 (0.61) ALDH1A1RAB9ASMN1; SMN2KDM4ENPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2394995-B1 RING-FUSED 2-PYRIDONE DERIVATIVES AND HERBICIDES KUMIAI CHEMICAL INDUSTRY CO (JP) 2014-01-15 EP disclosed
US-8334236-B2 Ring-fused 2-pyridone derivatives and herbicides KUMIAI CHEMICAL INDUSTRY CO., LTD. (JP) 2012-12-18 US disclosed
EP-2394995-A1 RING-FUSED 2-PYRIDONE DERIVATIVES AND HERBICIDES Kumiai Chemical Industry CO., LTD. (JP) 2011-12-14 EP disclosed
US-20110287937-A1 RING-FUSED 2-PYRIDONE DERIVATIVES AND HERBICIDES IHARA CHEMICAL INDUSTRY CO., LTD. (JP) 2011-11-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110287937-A1 RING-FUSED 2-PYRIDONE DERIVATIVES AND HERBICIDES CBR3, CBR1, CHRM1 ALDH1A1 623/4885RAB9A 3900/4885SMN1; SMN2 2712/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.